HRTX
Heron Therapeutics Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
heron therapeutics, inc. (formerly a.p. pharma, inc.) is a specialty pharmaceutical company developing products using its proprietary biochronomer™ polymer-based drug delivery platform. this drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
Market Cap: 372 Million
Primary Exchange: NASDAQ
Website: http://www.herontx.com/
Shares Outstanding: 150 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.8071866171544182
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1915 trading days
From: 2018-06-27 To: 2024-03-07
Lowest Point:
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Heron Therapeutics, Inc.
via: Business Wire at 2019-06-13 14:18:00:000
Law Offices of Howard G. Smithreminds investors of the upcoming August 5, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Heron Therapeutics, Inc. (Heron Therapeutics or the Companyȁ… read more...
Heron Therapeutics to Present at 2019 JMP Securities Life Sciences Conference
via: PR Newswire at 2019-06-13 12:05:00:000
SAN DIEGO , June 13, 2019 /PRNewswire/ --Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced tha… read more...
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Heron Therapeutics, Inc. - HRTX
via: PR Newswire at 2019-06-12 12:45:00:000
NEW YORK , June 12, 2019 /PRNewswire/ --Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Heron Therapeutics, Inc. (NASDAQ: HRTX) from October 31, 2018 through April 30 , 2019,inclu… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2014-01-13 | 20.0 | 1.0 | 20.0 |